Novo Nordisk A/S (NYSE:NVO)

Delayed Data
As of Mar 16
 +0.05 / +0.10%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 30 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 56.97, with a high estimate of 72.88 and a low estimate of 32.92. The median estimate represents a +12.94% increase from the last price of 50.44.

Analyst Recommendations

The current consensus among 31 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 27.21%
Growthannually 6.97%


Growthquarterly 1.71%
Growthannually 1.54%
Key to the earnings and sales forecast charts.